December 13, 2018
Oncopeptides Capital Markets Day December 14th in New York
Media
December 13, 2018
Orexo regains rights to Zubsolv® in all countries outside the US
December 12, 2018
Targovax Presents at DNB 9th Annual Nordic Healthcare Conference
December 12, 2018
National Institute for Health and Care Excellence (NICE) issues new guidelines for COPD, Recommending severe patients be evaluated for bronchoscopic lung volume reduction
December 12, 2018
GenSight Biologics reports sustained quality of life improvements at Week 72 of Phase III REVERSE clinical trial of GS010 for the treatment of Leber Hereditary Optic Neuropathy (LHON)
December 06, 2018
Orexo hosts Capital Markets Day today in Stockholm, Sweden
December 05, 2018
CERENIS announces the results of TANGO, a Phase III clinical study evaluating CER-001 in patients with HDL deficiency
December 05, 2018
Program for Oncopeptides Capital Markets Day December 14th, 2018
December 04, 2018
Nordic Nanovector: Additional preclinical studies with CD37-targeting radioimmunotherapies for B-cell malignancies presented at ASH
December 03, 2018
Interim data from the ongoing HORIZON trial with melflufen presented in an oral presentation at the 60th American Society of Hematology Meeting